SCCA at
Transplantation & Cellular Therapy 2021
February 8-12, 2021
Virtual Online

World-class physicians and researchers from Seattle Cancer Care Alliance (SCCA) and our partner, Fred Hutchinson Cancer Research Center, will present their pioneering research on cellulary therapy as well as blood and marrow transplantation at the Transplantation & Cellular Therapy Meetings (TCT Meetings). 

TCT Meetings are the combined annual meetings of the American Society for Transplantation and Cellular Therapy (ASTCT) and the Center for International Blood & Marrow Transplant Research (CIBMTR).

These files provide more information on a variety of information related to our programs, clinical trials, our physician team, the fellowship program, and open job opportunities.

Schedule and abstracts

A highlighted selection of the schedule and abstracts from our leading physician researchers at this year's virtual conference. 

Filter conference by
Selected tags
Monday, February 8th
8:30 AM - 5:00 PM
IL-15 Serum Concentrations and CD19 CAR T-Cell Therapy: Impact on Clinical Outcomes and In Vivo CAR T Cell Kinetics
Speaker
Jordan Gauthier, MD, MSc
Disease/Specialty
CAR T-cell therapy
9:30 AM - 10:00 AM
Therapeutic Trials in Chronic GVHD
Speaker
Stephanie J. Lee, MD, MPH
Disease/Specialty
Graft-versus-Host Disease
Tuesday, February 9th
8:30 AM - 5:00 PM
IL-15 Serum Concentrations and CD19 CAR T-Cell Therapy: Impact on Clinical Outcomes and In Vivo CAR T Cell Kinetics
Speaker
Jordan Gauthier, MD, MSc
Disease/Specialty
CAR T-cell therapy
Wednesday, February 10th
8:30 AM - 5:00 PM
IL-15 Serum Concentrations and CD19 CAR T-Cell Therapy: Impact on Clinical Outcomes and In Vivo CAR T Cell Kinetics
Speaker
Jordan Gauthier, MD, MSc
Disease/Specialty
CAR T-cell therapy
8:45 AM - 9:30 AM
Return to Work Guidance for the Adult Stem Cell Transplant Recipient
Speaker
Rachel B. Salit, MD
Disease/Specialty
Blood and marrow transplant
Return to School Practices During COVID-19
Speaker
Neel S. Bhatt, MBBS, MPH
Disease/Specialty
COVID-19
11:15 AM - 12:15 PM
Infection Prevention for BMT/Immunotherapy Patients in the Time of COVID-19
Speaker
Steven A. Pergam, MD, MPH
Disease/Specialty
COVID-19
11:30 AM - 12:30 PM
How I Treat Chronic GVHD
Speaker
Mary E. Flowers, MD
Disease/Specialty
Graft-versus-Host Disease
3:00 PM - 4:00 PM
How I Treat Chronic GVHD
Speaker
Mary E. Flowers, MD
Disease/Specialty
Graft-versus-Host Disease
Thursday, February 11th
8:30 AM - 5:00 PM
IL-15 Serum Concentrations and CD19 CAR T-Cell Therapy: Impact on Clinical Outcomes and In Vivo CAR T Cell Kinetics
Speaker
Jordan Gauthier, MD, MSc
Disease/Specialty
CAR T-cell therapy
1:00 PM - 1:15 PM
Which Respiratory Virus Infections Are Associated with Increased Risk of Specific Bacterial Infection in Allogeneic Hematopoietic Cell Transplant Recipients?
Speaker
Chikara Ogimi, MD
Disease/Specialty
Blood and marrow transplant

Speakers

More than 20 members of our leading-edge research team will be sharing their latest findings. Here are some of the highlights.

Additional conference speakers

Neel S. Bhatt, MBBS, MPH
Neel S. Bhatt, MBBS, MPH
Expand icon
Mary E. Flowers, MD
Mary E. Flowers, MD
Expand icon
Steven A. Pergam, MD, MPH
Steven A. Pergam, MD, MPH
Expand icon
Rachel B. Salit, MD
Rachel B. Salit, MD
Expand icon
Karen L. Syrjala, PhD
Karen L. Syrjala, PhD
Expand icon

Contact us

SCCA Media Relations
Heather Platisha
Media Relations Manager